Randall Pellish to Humans
This is a "connection" page, showing publications Randall Pellish has written about Humans.
Connection Strength
0.144
-
Cappuccio JM, Mehta N, Pellish R. Inpatient Infliximab Biosimilar Cost-Savings: Cost Analysis of Inpatient Treatment with Originator Infliximab (Remicade?) versus Biosimilar Infliximab (Renflexis?) for Acute Severe Ulcerative Colitis. Dig Dis. 2024; 42(5):496-502.
Score: 0.036
-
Osman KT, Hoque A, Pasam RT, Farhoud A, Abdelfattah A, Ramadorai V, Chaudrey K, Pellish R. Acute idiopathic pancreatitis is associated with more aggressive disease course in Crohn's disease but not in ulcerative colitis. BMC Gastroenterol. 2023 May 22; 23(1):171.
Score: 0.033
-
Hsu A, Belkin E, Han S, Pellish R. Tamoxifen-associated portal vein thrombosis causing severe oesophageal variceal bleeding. BMJ Case Rep. 2015 Aug 27; 2015.
Score: 0.019
-
Han S, Shannahan S, Pellish R. Fecal Microbiota Transplant: Treatment Options for Clostridium difficile Infection in the Intensive Care Unit. J Intensive Care Med. 2016 Oct; 31(9):577-86.
Score: 0.019
-
Hohenhaus MH, Pellish RS. Miriam Hospital and Rhode Island Hospital morbidity and mortality conferences, two cases of sudden weakness. Med Health R I. 2005 Jan; 88(1):27-9.
Score: 0.009
-
Olendzki B, Bucci V, Cawley C, Maserati R, McManus M, Olednzki E, Madziar C, Chiang D, Ward DV, Pellish R, Foley C, Bhattarai S, McCormick BA, Maldonado-Contreras A. Dietary manipulation of the gut microbiome in inflammatory bowel disease patients: Pilot study. Gut Microbes. 2022 Jan-Dec; 14(1):2046244.
Score: 0.008
-
Grossberg LB, Pellish RS, Cheifetz AS, Feuerstein JD. Review of Societal Recommendations Regarding Management of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic. Inflamm Bowel Dis. 2021 05 17; 27(6):940-946.
Score: 0.007
-
Stein BN, Pellish RS, Thompson KD, Baptista V, Siegel CA. Using Therapeutic Drug Monitoring to Identify Variable Infliximab Metabolism in an Individual Patient With Ulcerative Colitis. J Clin Gastroenterol. 2016 Jan; 50(1):66-8.
Score: 0.005
-
Juillerat P, Wasan SK, Fowler SA, Friedman S, Pabby VK, Coukas JA, Barto AE, Pellish R, Germansky KA, Cheifetz AS, Korzenik JR, Farraye FA, Yajnik V. Efficacy and safety of natalizumab in Crohn's disease patients treated at 6 Boston academic hospitals. Inflamm Bowel Dis. 2013 Oct; 19(11):2457-63.
Score: 0.004
-
DeMarco DC, Odstrcil E, Lara LF, Bass D, Herdman C, Kinney T, Gupta K, Wolf L, Dewar T, Deas TM, Mehta MK, Anwer MB, Pellish R, Hamilton JK, Polter D, Reddy KG, Hanan I. Impact of experience with a retrograde-viewing device on adenoma detection rates and withdrawal times during colonoscopy: the Third Eye Retroscope study group. Gastrointest Endosc. 2010 Mar; 71(3):542-50.
Score: 0.003